Equitec Proprietary Markets’s Meridian Bioscience Inc VIVO Stock Holding History

Equitec Proprietary Markets’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-300	Closed	-$9.96K	–	223
2022 Q4	$9.96K	Hold	300	–	–	﹤0.01%	132
2022 Q3	$9K	Buy	+300	New	+$9.71K	﹤0.01%	183

Other funds holding VIVO

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Equitec Proprietary Markets's VIVO Position: Q1 2023 in Review

Equitec Proprietary Markets sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 300 shares — an estimated $9.96K sold.

Equitec Proprietary Markets first reported a position in VIVO in Q3 2022 and held it in 2 quarters. The position peaked at $9.96K in Q4 2022. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

Equitec Proprietary Markets reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
Equitec Proprietary Markets sold 300 Meridian Bioscience Inc shares in Q1 2023, an estimated $9.96K.
Equitec Proprietary Markets first reported a position in Meridian Bioscience Inc in Q3 2022 and held it in 2 quarters.
Equitec Proprietary Markets's Meridian Bioscience Inc position peaked at $9.96K in Q4 2022.
2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on Equitec Proprietary Markets's 13F filing for Q1 2023, filed 28 Apr 2023.